What’s Next for Xoma Corporation (NASDAQ:XOMA) After Having Less Shares Shorted?

June 15, 2018 - By Henry Gaston

XOMA Corporation (NASDAQ:XOMA) Logo

The stock of Xoma Corporation (NASDAQ:XOMA) registered a decrease of 7.26% in short interest. XOMA’s total short interest was 444,300 shares in June as published by FINRA. Its down 7.26% from 479,100 shares, reported previously. With 89,300 shares average volume, it will take short sellers 5 days to cover their XOMA’s short positions. The short interest to Xoma Corporation’s float is 7.35%.

The stock decreased 2.25% or $0.49 during the last trading session, reaching $21.3. About 199,573 shares traded or 64.60% up from the average. XOMA Corporation (NASDAQ:XOMA) has risen 273.57% since June 15, 2017 and is uptrending. It has outperformed by 261.00% the S&P500.

XOMA Corporation discovers, develops, and commercializes antibody therapeutics in the United States, Europe, and the Asia Pacific. The company has market cap of $178.22 million. The company??s product candidates include X358, a human negative allosteric modulating insulin receptor antibody that is in Phase II proof-of-concept study for the treatment of patients with hypoglycemia due to congenital hyperinsulinism and hypoglycemia in post-bariatric surgery patients; X213, a allosteric inhibitor for the treatment of prolactinoma and anti-psychotic-induced hyperprolactinemia; and X129, a potent fragment of a monoclonal antibody for the treatment of patients with acute severe hypoglycemia. It has a 9.69 P/E ratio. The Company’s preclinical product candidates comprise interleukin 2 for the treatment of metastatic melanoma and renal cell carcinoma; and anti-parathyroid receptor, a G-protein-coupled receptor for the treatment of hyperparathyroidism and humoral hypercalcemia of malignancy.

XOMA Corporation (NASDAQ:XOMA) Ratings Coverage

Among 2 analysts covering Xoma Corp (NASDAQ:XOMA), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Xoma Corp had 6 analyst reports since December 19, 2017 according to SRatingsIntel. The firm has “Buy” rating given on Thursday, January 18 by H.C. Wainwright. The firm has “Buy” rating given on Monday, May 21 by Wedbush. The stock of XOMA Corporation (NASDAQ:XOMA) earned “Buy” rating by H.C. Wainwright on Monday, April 30. The stock of XOMA Corporation (NASDAQ:XOMA) has “Buy” rating given on Tuesday, December 19 by Wedbush. As per Tuesday, February 6, the company rating was maintained by Wedbush. H.C. Wainwright maintained the stock with “Buy” rating in Friday, March 9 report.

XOMA Corporation (NASDAQ:XOMA) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: